CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 29.772
EU - Europa 17.756
AS - Asia 6.786
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 25
AF - Africa 21
OC - Oceania 6
Totale 54.403
Nazione #
US - Stati Uniti d'America 29.718
GB - Regno Unito 7.554
CN - Cina 2.746
IT - Italia 2.288
DE - Germania 2.082
SE - Svezia 1.847
UA - Ucraina 1.766
SG - Singapore 1.711
HK - Hong Kong 1.187
FI - Finlandia 898
TR - Turchia 842
BG - Bulgaria 650
FR - Francia 206
RU - Federazione Russa 141
IN - India 91
IE - Irlanda 64
IR - Iran 45
LT - Lituania 45
CA - Canada 42
KR - Corea 41
ES - Italia 38
NL - Olanda 36
PL - Polonia 36
ID - Indonesia 29
VN - Vietnam 26
BE - Belgio 24
EU - Europa 24
BR - Brasile 22
MY - Malesia 21
CH - Svizzera 17
PT - Portogallo 14
CL - Cile 12
JP - Giappone 12
DK - Danimarca 11
IL - Israele 8
MX - Messico 8
GR - Grecia 6
ZA - Sudafrica 6
BY - Bielorussia 5
LY - Libia 5
AU - Australia 4
CZ - Repubblica Ceca 4
PH - Filippine 4
RO - Romania 4
AT - Austria 3
EG - Egitto 3
HU - Ungheria 3
KZ - Kazakistan 3
PK - Pakistan 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
BZ - Belize 2
HR - Croazia 2
MC - Monaco 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SA - Arabia Saudita 2
SM - San Marino 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BH - Bahrain 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VE - Venezuela 1
YE - Yemen 1
Totale 54.403
Città #
Southend 7.074
Jacksonville 4.026
Fairfield 3.613
Dearborn 2.598
Woodbridge 2.279
Chandler 2.083
Ashburn 1.769
Houston 1.729
Wilmington 1.442
Singapore 1.391
Ann Arbor 1.232
Seattle 1.205
Hong Kong 1.183
Cambridge 1.149
Nyköping 1.120
Beijing 1.058
Princeton 757
Sofia 650
Eugene 640
Modena 604
Izmir 425
Bremen 423
San Diego 369
Santa Clara 268
Helsinki 261
New York 187
Des Moines 185
Milan 137
Shanghai 126
Norwalk 105
London 92
Hefei 91
Kunming 78
Rome 78
Nanjing 75
Dublin 64
Guangzhou 63
San Mateo 50
Boardman 45
Falls Church 43
Redwood City 41
Verona 40
Dongguan 35
Jinan 35
Bologna 34
Nanchang 33
Grafing 32
Augusta 30
Kraków 30
Jakarta 25
Dong Ket 22
Saint Petersburg 21
Brussels 20
Fuzhou 20
Hebei 20
Hounslow 19
Kilburn 19
Ardabil 18
Mountain View 18
Shenyang 18
Monmouth Junction 17
Turin 17
Wuhan 17
Dallas 16
Los Angeles 16
Philadelphia 16
Chiswick 15
Florence 15
Leawood 15
Orsogna 15
Parma 15
Xian 15
Palermo 14
Catania 13
Toronto 13
Genoa 12
Jinhua 12
San Francisco 12
Andover 11
Chicago 11
Jiaxing 11
Prescot 11
Solignano Nuovo 11
Torino 11
Tulare 11
Washington 11
Aosta 10
Baotou 10
Borås 10
Chongqing 10
Mumbai 10
Zhengzhou 10
Bari 9
Hanover 9
Indiana 9
Islington 9
San Jose 9
Southwark 9
Albignasego 8
Cornigliano 8
Totale 41.780
Nome #
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 260
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 243
Recommendations for contraception in women with diabetes. AMD-SIC position paper 209
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 201
Intermenstrual pelvic pain, quality of life and mood 200
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 199
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 192
Adenomyosis of the Extrapelvic Portion of the Round Ligament 191
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 191
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 191
Metabolic impact of combined hormonal contraceptives containing estradiol 186
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 186
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 185
Folate administration decreases oxidative status and blood pressure in postmenopausal women 184
Intensity of menstrual pain and estimated angle of uterine flexion 184
Association between urinary incontinence and climacteric symptoms in postmenopausal women 181
Medical and patient attitude towards vaginal atrophy: the AGATA study 173
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 173
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 173
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 172
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 171
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 171
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 171
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 170
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 168
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 166
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 164
Pharmacokinetic evaluation of desogestrel as a female contraceptive 164
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 163
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 160
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 159
Seasonal trend of acute pelvic inflammatory disease 159
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 157
Role of melatonin in circadian rhythm at menopause 155
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 153
Prevalence of menstrual pain in young women: what is dysmenorrhea 152
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 152
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 152
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 152
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 152
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 151
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 151
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 150
Amplification of pulsatile LH secretion by exogenous melatonin in women 150
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 149
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 149
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 148
Amplification of pulsatile LH secretion by exogenous melatonin in women. 148
Melatonin in relation to physiology in adult humans 147
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 147
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 147
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 145
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 145
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 145
Influence of melatonin and photoperiod on animal and human reproduction 144
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 144
Dienogest mediates midkine suppression in endometriosis 144
Prolonged melatonin administration decreases nocturnal blood pressure in women 143
European society of contraception statement on contraception in obese women 143
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 142
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 141
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 141
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 140
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 139
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 137
Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women. 137
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 136
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 134
Estrogeni e ossido nitrico: un sinergismo. 134
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 134
Oral contraceptives and bone metabolism. 133
Biometrical threshold of biparietal diameter for certain fetal sex assignment by ultrasound. 133
Oral contraceptives and insulin sensitivity 132
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 132
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 131
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 131
Anello Contraccettivo: i vantaggi della somministrazione vaginale 129
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 129
A role for melatonin in PCOS? 127
Melatonin enhances cortisol levels in aged women: reversible by estrogens. 127
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 127
The effect of menopause on blood lipid and lipoprotein levels 126
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 126
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: A double-blind, placebo-controlled study 126
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 126
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 125
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 125
Melatonin in aged women. Possible modulation by estrogens. 125
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 124
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 124
Drospirenone: dati di sicurezza a lungo termine 124
Potentially beneficial cardiovascular effects of melatonin administration in women. 124
A comparison of the central effects of different progestins used in hormone replacement therapy 124
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 122
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 122
Effetti dell’ HRT e SERM sulla pressione arteriosa 122
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 122
Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. 122
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 122
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 121
Totale 15.173
Categoria #
all - tutte 217.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.316 0 0 0 0 1.463 2.051 2.153 867 1.044 359 909 470
2020/20217.786 1.066 188 699 655 926 334 966 1.038 257 1.005 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/20252.378 486 186 115 1.142 449 0 0 0 0 0 0 0
Totale 54.954